Could Synthetic Data Predict Rare Adverse Events?

Accenture Surveys Tech Trends In Life Sciences

Accenture released its Life Sciences Technology Vision 2022 report, including a survey of biopharma execs on trends like synthetic data and quantum computing.

Wireframe DNA sequence molecules structure mesh. Hands of robot and human touching on DNA connecting in virtual interface on future. Artificial intelligence technology concept. Vector illustration. — Accenture released its 2022 tech trends report on 22 August • Source: Shutterstock

Among the variety of potential ways to utilize synthetic data in drug development that have been floated in recent years, one that may prove especially useful is providing a means to predict rare adverse events that may not appear until after the drug reaches the market. However, it could also be some time before that technology is possible, as there remain validation issues with the use of synthetic data.

Accenture included synthetic data among the trends listed in its Life Sciences Technology Vision 2022 report, which it released on...